相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rationale and prospects for novel pneumococcal vaccines
Kristin Moffitt et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization
Christopher J. Greene et al.
INFECTION AND IMMUNITY (2016)
Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice
Benjamin Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection
Dennis W. Metzger et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques
Y. Fukuyama et al.
MUCOSAL IMMUNOLOGY (2015)
Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
Susanna Esposito et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia
Keven M. Robinson et al.
RESPIRATORY RESEARCH (2015)
Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia
Agnieszka Rynda-Apple et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Protective properties of a fusion pneumococcal surface protein A (PspA) vaccine against pneumococcal challenge by five different PspA clades in mice
Zhenyu Piao et al.
VACCINE (2014)
Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniae
Il Gyu Kong et al.
INFECTION AND IMMUNITY (2013)
Two DHH Subfamily 1 Proteins in Streptococcus pneumoniae Possess Cyclic Di-AMP Phosphodiesterase Activity and Affect Bacterial Growth and Virulence
Yinlan Bai et al.
JOURNAL OF BACTERIOLOGY (2013)
PspA Family Distribution, Antimicrobial Resistance and Serotype of Streptococcus pneumoniae Isolated from Upper Respiratory Tract Infections in Japan
Muneki Hotomi et al.
PLOS ONE (2013)
Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons
Angela Dominguez et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
PspA Family Distribution, unlike Capsular Serotype, Remains Unaltered following Introduction of the Heptavalent Pneumococcal Conjugate Vaccine
Christina M. Croney et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia
Catia Cilloniz et al.
JOURNAL OF INFECTION (2012)
Type I Interferon Induction during Influenza Virus Infection Increases Susceptibility to Secondary Streptococcus pneumoniae Infection by Negative Regulation of γδ T Cells
Wenjing Li et al.
JOURNAL OF VIROLOGY (2012)
Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice
Shigeki Nakamura et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Influenza A Inhibits Th17-Mediated Host Defense against Bacterial Pneumonia in Mice
Anupa Kudva et al.
JOURNAL OF IMMUNOLOGY (2011)
Co-detection of Pandemic (H1N1) 2009 Virus and Other Respiratory Pathogens
Kassi Koon et al.
EMERGING INFECTIOUS DISEASES (2010)
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
Arash Shahangian et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Important Role for CC Chemokine Ligand 2-Dependent Lung Mononuclear Phagocyte Recruitment to Inhibit Sepsis in Mice Infected with Streptococcus pneumoniae
Christine Winter et al.
JOURNAL OF IMMUNOLOGY (2009)
Pneumococcal Surface Protein A Contributes to Secondary Streptococcus pneumoniae Infection after Influenza Virus Infection
Quinton O. King et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection
Keer Sun et al.
NATURE MEDICINE (2008)
The 1918 influenza pandemic: Insights for the 21st century
David M. Morens et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
A role for Streptococcus pneumoniae in virus-associated pneumonia
SA Madhi et al.
NATURE MEDICINE (2004)
IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection
KF van der Sluijs et al.
JOURNAL OF IMMUNOLOGY (2004)
Lethal Synergism between influenza virus and Streptococcus pneumoniae:: Characterization of a mouse model and the role of platelet-activating factor receptor
JA McCullers et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection
BP Arulanandam et al.
INFECTION AND IMMUNITY (2001)
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
DE Briles et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Diversity of PspA:: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae
SK Hollingshead et al.
INFECTION AND IMMUNITY (2000)
Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules
GS Nabors et al.
VACCINE (2000)
分享论文
